The role of FLT3 in haematopoietic malignanciesDerek L. Stirewalt(Fred Hutch Cancer Center), Jerald P. Radich(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)Nature reviews. CancerSeptember 1, 200310.1038/nrc1169Cited by 852SaveCiteExport RISWatch citationsAbstractRelated Papersc-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct ActivitiesStewart D. Lyman, Sten Eirik W. Jacobsen|Blood|1998|700Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathwaysMasao Mizuki, R. Fenski, Hartmut Halfter et al.|Blood|2000|580Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemiasCE Carow, Mark E. Levenstein, Scott H. Kaufmann et al.|Blood|1996|344Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cellsOlivier Rosnet, Claudine Schiff, MJ Pébusque et al.|Blood|1993|340Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cellsSD Lyman, L James, L Johnson et al.|Blood|1994|310